COVID-19 vaccine-associated autoimmune thyroid eye disease: Graves’ orbitopathy
- 28 September 2026
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 91 (1) , 320
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- The predictive, preventive, and personalised medicine of thyroid eye disease: a comprehensive guide to risk minimizationEPMA Journal, 2026
- Human Papillomavirus and Thyroid Eye DiseaseJAMA Ophthalmology, 2025
- Potential impacts of SARS-CoV-2 on parathyroid: current advances and trendsEndocrine, 2023
- A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19Rheumatology International, 2023
- Graves’ orbitopathy post-SARS-CoV-2 vaccines: report on six patientsJournal of Endocrinological Investigation, 2022
- Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccineClinical Case Reports, 2022
- Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathyJournal of Endocrinological Investigation, 2021
- SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ diseaseEndocrine, 2021
- Graves’ disease and Graves’ orbitopathy following COVID-19Journal of Endocrinological Investigation, 2021
- Smoking a risk factor for hyperthyroidismJournal of Endocrinological Investigation, 1993